Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Epidemiologic status of colorectal carcinoma in Yugoslavia].
Djordević M, Babić M, Drecun V, Kovcin V, Granić M, Petrović N. Djordević M, et al. Among authors: kovcin v. Acta Chir Iugosl. 1998;45(2 Suppl):17-21. Acta Chir Iugosl. 1998. PMID: 10951781 Croatian. No abstract available.
Multivariate analysis of prognostic factors in male breast cancer in Serbia.
Sipetic-Grujicic SB, Murtezani ZH, Neskovic-Konstatinovic ZB, Marinkovic JM, Kovcin VN, Andric ZG, Kostic SV, Ratkov IS, Maksimovic JM. Sipetic-Grujicic SB, et al. Among authors: kovcin vn. Asian Pac J Cancer Prev. 2014;15(7):3233-8. doi: 10.7314/apjcp.2014.15.7.3233. Asian Pac J Cancer Prev. 2014. PMID: 24815476 Free article.
[Evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin C in locally advanced and metastatic gastric cancer].
Andrić Z, Randjelović T, Kovčin V, Gutović J, Crevar S, Murtezani Z, Kostić S. Andrić Z, et al. Among authors: kovcin v. Srp Arh Celok Lek. 2012 May-Jun;140(5-6):305-12. doi: 10.2298/sarh1206305a. Srp Arh Celok Lek. 2012. PMID: 22826983 Free article. Clinical Trial. Serbian.
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.
Hanna NH, Kaiser R, Sullivan RN, Aren OR, Ahn MJ, Tiangco B, Voccia I, Pawel JV, Kovcin V, Agulnik J, Gaschler-Markefski B, Barrueco J, Sikken P, Schloss C, Kim JH; LUME-Lung 2 Study group. Hanna NH, et al. Among authors: kovcin v. Lung Cancer. 2016 Dec;102:65-73. doi: 10.1016/j.lungcan.2016.10.011. Epub 2016 Oct 27. Lung Cancer. 2016. PMID: 27987591 Clinical Trial.
47 results